Literature DB >> 487645

A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.

P Mar, T Gradl, C Dörner, I Contag.   

Abstract

In a 1 year longitudinal study of twenty-two patients with multiple sclerosis (MS) and twenty-one normal control subjects, peripheral blood leucocytes were stimulated with lipoplysaccharide (LPS), a B cell mitogen, and phytohaemagglutinin (PHA) a T cell mitogen. EA- and EAC-rosette formation was also performed to assay null and B cells respectively, and the serum concentration of the C3 component of complement was determined. For ten multiple sclerosis (MS) patients with stationary phases of the disease, percentages of lymphocytes significantly lower than normal were found with normal leucocyte counts in the peripheral blood. Lymphocyte stimulation by PHA was significantly lower than normal in stable MS, while neither LPS stimulation nor EA- and EAC-rosette formation differed significantly from the controls. The C3 serum concentration was found to be significantly higher than normal. For nine out of twelve MS patients with a fluctuating clinical course, the C3 concentration was elevated during remission, but dropped to normal levels during relapse. None of the other parameters studied could be correlated with the clinical course.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487645      PMCID: PMC1537761     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  T and B lymphocytes in multiple sclerosis.

Authors:  R P Lisak; A I Levinson; B Zweiman; N I Abdou
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

2.  Selected immunologic parameters of demyelinative diseases.

Authors:  D H Silberberg; R P Lisak; B Zweiman
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

3.  DEMONSTRATION OF COMPLEMENT IN SPINAL FLUID IN MULTIPLE SCLEROSIS.

Authors:  E KUWERT; E PETTE; W FIRNHABER; K MAI
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

4.  Partial purification and characterization of a lymphotoxic factor from multiple sclerosis serum.

Authors:  G White; S Armentrout; S van den Noort
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

5.  [Complement system and liquor cerebrospinalis. 3. The behavior of complete C' and C'1-C'4 in serum and liquor of patients with multiple sclerosis].

Authors:  E Kuwert; K Noll; W Firnhaber
Journal:  Z Immunitatsforsch Allerg Klin Immunol       Date:  1968-07

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Hypocomplementaemic multiple sclerosis: heterozygous C2 deficiency linked to HLA A10, B18.

Authors:  P Trouillas; F Berthoux; H Betuel; D Boisson; G Aimard; M Devic
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

8.  Complement factors in multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

9.  B and T lymphocytes in man. III. B, t, and "null" lymphocytes in multiple sclerosis.

Authors:  M M Reddy; K O Goh
Journal:  Neurology       Date:  1976-10       Impact factor: 9.910

10.  [Cerebrospinal fluid complement and multiple sclerosis].

Authors:  H Bammer
Journal:  Dtsch Z Nervenheilkd       Date:  1966-03-08
View more
  1 in total

Review 1.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.